Advanced Sterilization Products (ASP), part of Johnson & Johnson Medical Devices Companies, announces that it submitted a 510(k) application to the Food and Drug Administration (FDA) for the ultra-fast STERRAD VELOCITY™ Biological Indicator (BI) System. Pending clearance, it will be the fastest hydrogen peroxide (H202) BI on the market, using a new, integrated reader to provide automated confirmation – within 30 minutes – that proper sterilization conditions have been achieved when instruments are reprocessed in STERRAD® Systems.
Ensuring instruments are properly sterilized is one way healthcare workers can help reduce the incidences of healthcare-associated infections (HAI). According to the Centers for Disease Control and Prevention, about one in every 25 hospitalized patients acquires at least one HAI.1 HAIs cause an estimated 75,000 deaths in the United States per year, with total annual costs amounting to almost $10 billion annually.
Given the constant demands placed on hospital operating rooms, speed and efficiency of in-house Central Sterile Services Departments (CSSDs) are critical to supplying properly reprocessed medical devices as needed. In CSSDs, BIs are used to test and confirm sterilization cycle performance and provide sterility assurance. However, with current BIs taking several hours or more to confirm results, many instruments are sent back to operating rooms without sterility assurance.
"For more than 20 years, the biggest need we have heard from CSSDs and infection control departments is for a BI that provides almost immediate confirmation of sterility assurance," said Suneel Shorey, vice president of ASP Global Marketing. "An ultra-fast system will help staff ensure every instrument has been properly sterilized and can be swiftly delivered back to the operating room to be used with patients."
The STERRAD VELOCITY™ BI Reader will enable synchronization of BI and sterilization cycle records through a barcode scanner and touchscreen. It will also feature a countdown display for each well and on-screen and audible alerts. The reader will be validated for use with the recently FDA-cleared STERRAD® 100NX® and NX® Systems with ALLClear™ Technology, as well as existing STERRAD® NX, 100NX® and 100S® System sterilizers.
Source: Advanced Sterilization Products
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.